{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:05:34Z","timestamp":1781651134604,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health Research School for Primary Care Research","award":["294"],"award-info":[{"award-number":["294"]}]},{"name":"NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West Midlands"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR-RP-2014-04-026"],"award-info":[{"award-number":["NIHR-RP-2014-04-026"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Clinician Scientist Fellowship award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00296-019-04422-5","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T11:03:33Z","timestamp":1566471813000},"page":"1789-1796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristics of patients with giant cell arteritis who experience visual symptoms"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-4078","authenticated-orcid":false,"given":"Chung Shen","family":"Chean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-2796","authenticated-orcid":false,"given":"James A.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3987-6045","authenticated-orcid":false,"given":"Toby","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6844-0932","authenticated-orcid":false,"given":"John","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-5873","authenticated-orcid":false,"given":"Sarah L.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-3909","authenticated-orcid":false,"given":"Samantha L.","family":"Hider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1059-1230","authenticated-orcid":false,"given":"Jennifer","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-1028","authenticated-orcid":false,"given":"Christian D.","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"issue":"3","key":"4422_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/acr.22429","volume":"67","author":"H Petri","year":"2015","unstructured":"Petri H, Nevitt A, Sarsour K et al (2015) Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities. Arthritis Care Res (Hoboken) 67(3):390\u2013395","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"suppl_2","key":"4422_CR2","doi-asserted-by":"publisher","first-page":"ii72","DOI":"10.1093\/rheumatology\/kex428","volume":"57","author":"I Vodopivec","year":"2018","unstructured":"Vodopivec I, Rizzo JF III (2018) Ophthalmic manifestations of giant cell arteritis. Rheumatology 57(suppl_2):ii72","journal-title":"Rheumatology"},{"issue":"599","key":"4422_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3399\/bjgp12X649313","volume":"62","author":"K Barraclough","year":"2012","unstructured":"Barraclough K, Mallen CD, Helliwell T et al (2012) Diagnosis and management of giant cell arteritis. Br J Gen Pract 62(599):329\u2013330","journal-title":"Br J Gen Pract"},{"issue":"1 Suppl 75","key":"4422_CR4","first-page":"S96","volume":"31","author":"M Figus","year":"2013","unstructured":"Figus M, Talarico R, D\u2019Ascanio A et al (2013) Ocular involvement in giant cell arteritis. Clin Exp Rheumatol 31(1 Suppl 75):S96","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4422_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","volume":"125","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B (1998) Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 125(4):521\u2013526","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"4422_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology 49(8):1594\u20131597","journal-title":"Rheumatology"},{"issue":"2","key":"4422_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10067-010-1616-y","volume":"30","author":"AN Ezeonyeji","year":"2011","unstructured":"Ezeonyeji AN, Borg FA, Dasgupta B (2011) Delays in recognition and management of giant cell arteritis: results from a retrospective audit. Clin Rheumatol 30(2):259\u2013262","journal-title":"Clin Rheumatol"},{"issue":"9","key":"4422_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.40520","volume":"70","author":"Kornelis SM van der Geest","year":"2018","unstructured":"van der Geest Kornelis SM, Sandovici M, van Sleen Y et al (2018) What is the current evidence for disease subsets in giant cell arteritis? Arthritis Rheumatol 70(9):1366\u20131376","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4422_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12916-017-0871-z","volume":"15","author":"JA Prior","year":"2017","unstructured":"Prior JA, Ranjbar H, Belcher J et al (2017) Diagnostic delay for giant cell arteritis\u2013a systematic review and meta-analysis. BMC Med 15(1):120","journal-title":"BMC Med"},{"issue":"2 Suppl 89","key":"4422_CR10","first-page":"6","volume":"33","author":"P Patil","year":"2015","unstructured":"Patil P, Williams M, Maw WW et al (2015) Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol 33(2 Suppl 89):6","journal-title":"Clin Exp Rheumatol"},{"key":"4422_CR11","unstructured":"Communities and neighbourhoods (2015) The English indices of deprivation 2015. \n                    https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015\n                    \n                  . Accessed 15 Feb 2019"},{"issue":"3","key":"4422_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware J Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220\u2013233","journal-title":"Med Care"},{"key":"4422_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams J et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097","journal-title":"Arch Intern Med"},{"key":"4422_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613","journal-title":"J Gen Intern Med"},{"issue":"2","key":"4422_CR15","first-page":"101","volume":"66","author":"F Kishimoto","year":"2012","unstructured":"Kishimoto F, Ohtsuki H (2012) Comparison of VF-14 scores among different ophthalmic surgical interventions. Acta Med Okayama 66(2):101\u2013110","journal-title":"Acta Med Okayama"},{"key":"4422_CR16","doi-asserted-by":"crossref","DOI":"10.1201\/9780429246593","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1994","unstructured":"Efron B, Tibshirani RJ (1994) An introduction to the bootstrap. CRC Press, London"},{"issue":"2","key":"4422_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3899\/jrheum.140188","volume":"42","author":"AG Singh","year":"2015","unstructured":"Singh AG, Kermani TA, Crowson CS et al (2015) Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheumatol 42(2):309\u2013315","journal-title":"J Rheumatol"},{"issue":"2","key":"4422_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/art.21075","volume":"53","author":"C Salvarani","year":"2005","unstructured":"Salvarani C, Cimino L, Macchioni P et al (2005) Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 53(2):293\u2013297","journal-title":"Arthritis Rheum"},{"issue":"3","key":"4422_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","volume":"111","author":"E Liozon","year":"2001","unstructured":"Liozon E, Herrmann F, Ly K et al (2001) Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 111(3):211\u2013217","journal-title":"Am J Med"},{"issue":"5","key":"4422_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","volume":"79","author":"MA Gonz\u00e1lez-Gay","year":"2000","unstructured":"Gonz\u00e1lez-Gay MA, Garc\u00eda-Porr\u00faa C, Llorca J et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine 79(5):283\u2013292","journal-title":"Medicine"},{"issue":"7","key":"4422_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/art.1780240706","volume":"24","author":"BA Bengtsson","year":"1981","unstructured":"Bengtsson BA, Malmvall BE (1981) The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 24(7):899\u2013904","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4422_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1080\/03009742.2016.1266030","volume":"46","author":"J Ji","year":"2017","unstructured":"Ji J, Dimitrijevic I, Sundquist J et al (2017) Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden. Scand J Rheumatol 46(6):484\u2013489","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"4422_CR23","doi-asserted-by":"publisher","first-page":"e017073","DOI":"10.1136\/bmjopen-2017-017073","volume":"7","author":"J Liddle","year":"2017","unstructured":"Liddle J, Bartlam R, Mallen CD et al (2017) What is the impact of giant cell arteritis on patients\u2019 lives? A UK qualitative study. BMJ Open 7(8):e017073","journal-title":"BMJ Open"},{"issue":"9","key":"4422_CR24","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-017-3619-4","volume":"36","author":"S Jobard","year":"2017","unstructured":"Jobard S, Magnant J, Blasco H et al (2017) Quality of life of patients treated for giant cell arteritis: a case-control study. Clin Rheumatol 36(9):2055\u20132062","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4422_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/00041327-200112000-00008","volume":"21","author":"MJ Kupersmith","year":"2001","unstructured":"Kupersmith MJ, Speira R, Langer R et al (2001) Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthalmol 21(4):266\u2013273","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"4422_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/archopht.1994.01090170074026","volume":"112","author":"EP Steinberg","year":"1994","unstructured":"Steinberg EP, Tielsch JM, Schein OD et al (1994) The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol 112(5):630\u2013638","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"4422_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/B:QURE.0000015298.09085.b0","volume":"13","author":"JM Valderas","year":"2004","unstructured":"Valderas JM, Alonso J, Prieto L et al (2004) Content-based interpretation aids for health-related quality of life measures in clinical practice. An example for the visual function index (VF-14). Qual Life Res 13(1):35\u201344","journal-title":"Qual Life Res"},{"issue":"5","key":"4422_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.7326\/0003-4819-101-5-594","volume":"101","author":"TS Larson","year":"1984","unstructured":"Larson TS, Hall S, Hepper N et al (1984) Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med 101(5):594\u2013597","journal-title":"Ann Intern Med"},{"issue":"2","key":"4422_CR29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/bjo.2004.047860","volume":"89","author":"MN Ali","year":"2005","unstructured":"Ali MN (2005) Hoarse voice and visual loss. Br J Ophthalmol 89(2):240","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"4422_CR30","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3899\/jrheum.151033","volume":"43","author":"M Saleh","year":"2016","unstructured":"Saleh M, Turesson C, Englund M et al (2016) Visual complications in patients with biopsy-proven giant cell arteritis: a population-based study. J Rheumatol 43(8):1559\u20131565","journal-title":"J Rheumatol"},{"issue":"3","key":"4422_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","volume":"48","author":"CT Berger","year":"2009","unstructured":"Berger CT, Wolbers M, Meyer P et al (2009) High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology 48(3):258\u2013261","journal-title":"Rheumatology"},{"key":"4422_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/09286586.2018.1513042","volume":"26","author":"VV Chirikov","year":"2019","unstructured":"Chirikov VV, Shah R, Kwon Y et al (2019) Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: real-world data analysis. Ophthalmic Epidemiol 26:27\u201346. \n                    https:\/\/doi.org\/10.1080\/09286586.2018.1513042","journal-title":"Ophthalmic Epidemiol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04422-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04422-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T23:11:12Z","timestamp":1597965072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04422-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4422"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04422-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]},"assertion":[{"value":"10 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}